Vitamin D: A dynamic molecule. How relevant might the dynamism for a vitamin be?

Nephrology Dialysis Transplantation

Volumn 31, Issue 1, 2016, Pages 23-30

  Mazzaferro, Sandro ^a,b   Pasquali, Marzia ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

Author keywords

FGF23; osteocalcin; siblings; Vitamin D; Vitamin D receptor

Indexed keywords

COLECALCIFEROL; DRUG METABOLITE; PARATHYROID HORMONE; VITAMIN D; VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR;

BONE CELL; ENERGY METABOLISM; HORMONE SYNTHESIS; HUMAN; HYPERTENSION; IMMUNE RESPONSE; METABOLIC REGULATION; MINERAL METABOLISM; MOLECULAR DYNAMICS; MOLECULAR EVOLUTION; MOLECULAR INTERACTION; MUSCULOSKELETAL SYSTEM; NONHUMAN; PLEIOTROPY; PREDICTION; PRIORITY JOURNAL; PROTEIN FUNCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; VITAMIN SUPPLEMENTATION; ANIMAL; BLOOD; EVOLUTION; PHYSIOLOGY; VITAMIN D DEFICIENCY;

ANIMALS; BIOLOGICAL EVOLUTION; HUMANS; RECEPTORS, CALCITRIOL; RENIN-ANGIOTENSIN SYSTEM; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84960095193     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfv340     Document Type: Review

References (55)

1. De Luca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004; 80 (suppl): 1689S-1696S
2. Norman AW. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 2008; 88 (suppl): 491S-499S
3. Holick MF. Vitamin D: evolutionary, physiological and health perspectives. Curr Drug Targets 2011; 12: 4-18
4. Fries L. D-Vitamins and their precursors as growth regulators in axenically cultivated marine macroalgae. J Phycol 1984; 20: 62-66
5. Kriajev L, Otremski I, Edelstein S. Calcium cells from snails: response to vitamin D metabolites. Calcif Tissue Int 1994; 55: 204-207
6. Wheatly MG. Calcium homeostasis in crustacea: the evolving role of branchial, renal, digestive and hypodermal epithelia. J Exp Zool 1999; 283: 620-640
7. Whitfield GK, Dang HT, Schluter SF, et al. Cloning of a functional vitamin D receptor from the lamprey (Petromyzon marinus), an ancient vertebrate lacking a calcified skeleton and teeth. Endocrinology 2003; 144: 2704-2716
8. Craig TA, Sommer S, Sussman CR, et al. Expression and regulation of the vitamin D receptor in the zebrafish, Danio rerio. J Bone Miner Res 2008; 23: 1486-1496
9. Howarth D, Law SHW, Barnes B, et al. Paralogous vitamin D receptors in teleosts: transition of nuclear receptor function. Endocrinology 2008; 149: 2411-2422
10. Bouillon B. The vitamin D binding protein DBP. In: Feldman D, Pike JW, Adams JS (eds). Vitamin D, 3rd edn. London: Academic Press, 2011, pp. 57-72
11. Bouillon R, Suda T. Vitamin D: calcium and bone homoeostasis during evolution. Bonekey Rep 2014; 3: 480
12. Brennan TS, Lowenstein TK, Horita J. Seawater chemistry and the advent of biocalcification. Geology 2004; 32: 473-476
13. On JS, Chow BK, Lee LT. Evolution of parathyroid hormone receptor family and their ligands in vertebrate. Front Endocrinol (Lausanne) 2015; 6: 28
14. Pi M, Quarles D. Novel bone endocrine networks integrating mineral and energy metabolism. Curr Osteoporos Rep 2013; 11: 391-399
15. Itoh N. Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease. Cell Tissue Res 2010; 342: 1-11
16. Shimada T, Mizutani S, Muto T, et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 2001; 98: 6500-6505
17. Faul C, Amaral AP, Oskouei B, et al. FGF23 induces left ventricular hypertrophy. J Clin Invest 2011; 121: 4393-4408
18. Hu MC, Shi M, Cho HJ, et al. Klotho and phosphate are modulators of pathologic uremic cardiac remodeling. J Am Soc Nephrol 2015; 26: 1290-1302
19. Andrukhova O, Slavic S, Smorodchenko A, et al. FGF23 regulates renal sodium handling and blood pressure. EMBO Mol Med 2014; 6: 744-759
20. Laize V, Martel P, Viegas CSB, et al. Evolution of matrix and bone ?-carboxyglutamic acid proteins in vertebrates. J Biol Chem 2005; 280: 26659-26668
21. Ducy P, Desbois C, Boyce B, et al. Increased bone formation in osteocalcindeficient mice. Nature 1996; 382: 448-452
22. Karsenty G, Ferron M. The contribution of bone to whole-organism physiology. Nature 2012; 481: 314-320
23. Sierra J, Villagra A, Paredes R, et al. Regulation of the bone-specific osteocalcin gene by p300 requires Runx2/Cbfa1 and the vitamin D3 receptor but not p300 intrinsic histone acetyltransferase activity. Mol Cell Biol 2003; 23: 3339-3351
24. Coen G, Mazzaferro S, Bonucci E, et al. Bone GLA protein in predialysis chronic renal failure. Effects of 1, 25(OH)2D3 administration in a long-Term follow-up. Kidney Int 1985; 28: 783-790
25. Fukumoto S, Martin TJ. Bone as an endocrine organ. Trends Endocrinol Metab 2009; 20: 230-236
26. Rowe PS. The chicken or the egg: PHEX, FGF23 and SIBLINGs unscrambled. Cell Biochem Funct 2012; 30: 355-375
27. Rowe PS. Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway. Crit Rev Eukaryot Gene Expr 2012; 22: 61-86
28. Di Girolamo DJ, Clemens TL, Kousteni S. The skeleton as an endocrine organ. Nat Rev Rheumatol 2012; 8: 674-683
29. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281
30. Wang WL, Tenniswood M. Vitamin D, intermediary metabolism and prostate cancer tumor progression. Front Physiol 2014; 5: 183
31. Kelsey L, Katoch P, Ray A, et al. Vitamin D3 regulates the formation and degradation of gap junctions in androgen-responsive human prostate cancer cells. PLoS One 2014; 9: e106437
32. Holick MF. McCollum Award Lecture, 1994: Vitamin D-new horizons for the 21st century. Am J Clin Nutr 1994; 60: 619-3021
33. Bishoff-Ferrari HA, Willett WC, Orav EJ, et al. Apooled analysis of vitaminD dose requirements for fracture prevention. N Engl J Med 2012; 367: 40-49
34. Ringe JD. The effect of Vitamin D on falls and fractures. Scand J Clin Lab Invest Suppl 2012; 243: 73-78
35. Rush L, McCartney G, Walsh D, et al. VitaminDand subsequent all-Age and premature mortality: a systematic review. BMC Public Health 2013; 13: 679
36. Spedding S, Vanlint S, Morris H, et al. Does vitamin D sufficiency equate to a single serum 25-hydroxyvitaminD level or are different levels required for non-skeletal diseases?. Nutrients 2013; 5: 5127-5539
37. Li YC, Kong J, Wei M, et al. 1, 25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-Angiotensin system. J Clin Invest 2002; 110: 229-238
38. Beveridge LA, Struthers AD, Khan F, et al. Effect of vitamin D supplementation on blood pressure. A systematic review and meta-Analysis incorporating individual patient data. JAMA Intern Med 2015; 175: 745-754
39. Nishimura H. Angiotensin receptors-evolutionary overview and perspectives. Comp Biochem Physiol A 2001; 128: 11-30
40. De Cavenag EMV, Inserra F, Ferder M, et al. From mitochondria to disease: role of the renin-Angiotensin system. Am J Nephrol 2007; 27: 545-553
41. Silvagno F, De Vivo E, Attanasio A, et al. Mitochondrial localization of vitamin D receptor in human platelets and differentiated megakaryocytes. PLoS ONE 2010; 5: e8670
42. Zhang Z, Yuan W, Sun L, et al. 1, 25-Dihydroxyvitamin D(3) targeting of NF-kappaB suppresses high glucose-induced MCP-1 expression in mesangial cells. Kidney Int 2007; 72: 193-201
43. Ferder M, Inserra F, Manucha Wet al. The world pandemic of vitamin D deficiency could possibly be explained by cellular inflammatory response activity induced by the renin-Angiotensin system. Am J Physiol Cell Physiol 2013; 304: C1027-C1039
44. Haussler MR, Jurutka PW, Mizwicki M, et al. Vitamin D receptor (VDR)-mediated actions of 1α, 25(OH)-vitamin D-: genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab 2011; 25: 543-559
45. Norman AW, Bishop JE, Collins ED, et al. Differing shapes of 1 alpha, 25-dihydroxyvitamin D3 function as ligands for the D-binding protein, nuclear receptor and membrane receptor: a status report. J Steroid Biochem Mol Biol 1996; 56 (1-6 Spec No): 13-22
46. Norman AW, Song X, Zanello L, et al. Rapid and genomic biological responses are mediated by different shapes of the agonist steroid hormone, 1alpha, 25(OH)2vitamin D3. Steroids 1999; 64: 120-128
47. Mizwicki MT, Norman AW. Two key proteins of the vitamin D endocrine system come into crystal clear focus: comparison of the X-ray structures of the nuclear receptor for 1alpha, 25(OH)2 vitamin D3, the plasma vitamin D binding protein, and their ligands. J Bone Miner Res 2003; 18: 795-806
48. Mizwicki MT, Bula CM, Bishop JE, et al. A perspective on how the vitamin D sterol/vitamin D receptor (VDR) conformational ensemble model can potentially be used to understand the structure-function results of A-ring modified vitamin D sterols. J Steroid Biochem Mol Biol 2005; 97: 69-82
49. Bouillon R, Okamura WH, Norman AW. Structure-function relationships in the vitamin D endocrine system. Endocr Rev 1995; 16: 200-257
50. Kusunoki Y, Matsui I, Hamano Tet al. Excess 25-hydroxyvitamin D3 exacerbates tubulointerstitial injury inmice bymodulatingmacrophage phenotype. Kidney Int 2015; 88: 1013-1029
51. Gacad MA, Chen H, Arbelle JE, et al. Functional characterization and purification of an intracellular vitamin D-binding protein in vitamin D-resistant new world primate cells. Amino acid sequence homology with proteins in the hsp-70 family. J Biol Chem 1997; 272: 8433-8440
52. De Clercq PJ, De Buysser F, Minne G, et al. The development of CD-ring modified analogs of 1alpha, 25-dihydroxyvitamin D. J Steroid Biochem Mol Biol 2007; 103: 206-212
53. Molnár F, Peräkylä M, Carlberg C. Vitamin D receptor agonists specifically modulate the volume of the ligand-binding pocket. J Biol Chem 2006; 281: 10516-10526
54. Molnár F. Structural considerations of vitamin D signaling. Front Physiol 2014; 5: 191
55. Mizwicki MT, Bula CM, Bishop JE, et al. New insights into Vitamin D sterol-VDR proteolysis, allostery, structure-function from the perspective of a conformational ensemble model. J Steroid Biochem Mol Biol 2007; 103: 243-262